Abstract
Introduction胸膜疾病的发病率升高正在看到胸腔服务的国际增长,与医生表现出不断增长的胸膜干预措施。这通常在没有立即访问胸外科或介入放射学的地点进行的。可能会报道严重的并发症,如胸膜出血。
目标为了评估肋间血管筛选是否可以在胸膜干预时由呼吸医生进行,作为可能提高安全实践的额外步骤。
MethodsThis was a prospective, observational study of 596 ultrasound-guided pleural procedures conducted by respiratory physicians and trainees in a tertiary centre. Operators did not have additional formal radiology training. Intercostal vessel screening was performed using a low frequency probe and the colour Doppler feature.
ResultsThe intercostal vessels were screened in 95% of procedures and the intercostal artery was successfully identified in 53%. Screening resulted in an overall site alteration rate of 16% in all procedures, which increased to 30% when the intercostal artery was successfully identified. This resulted in procedure abandonment in 2% of cases due to absence of a suitable entry site. Intercostal vessel screening was shown to be of particular value in the context of image-guided pleural biopsy.
Conclusion肋间血管筛查是一种简单且潜在的重要额外步骤,可以通过胸膜干预时的呼吸师医师进行,而无需高级超声专业知识。这种技术的广泛使用是否可以提高安全性需要进一步评估,在多中心设置中具有鲁棒的前瞻性研究。
Footnotes
This manuscript has recently been accepted for publication in the欧洲呼吸杂志。在我们的制作团队中的复制和排版之前,它在其接受的表单中发布。在这些生产过程完成后,作者已批准所产生的证据,这篇文章将转向最新问题erj.online. Please open or download the PDF to view this article.
利益冲突:Bedawi博士没有披露。
利益冲突:Talwar博士无需披露。
利益冲突:哈桑博士没有披露。
Conflict of interest: Dr. McCracken has nothing to disclose.
利益冲突:Asciak博士无需披露。
利益冲突:Mercer博士没有披露。
利益冲突:卡奈克斯博士无需披露。
Conflict of interest: Dr. Gleeson has nothing to disclose.
利益冲突:Hallifax博士没有什么可披露的。
兴趣冲突:Wrightson博士没有什么可披露的。
利益冲突:拉赫曼博士无需披露。
这是一个仅限PDF的文章。请单击上面的PDF链接以阅读它。
- Received2019年11月20日。
- 公认2020年2月1日。
- 版权所有©ers 2020